Question 1

What is the catalog number for N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide?

Accepted Answer

The catalog number for N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide is AAA09875.

Question 2

What sizes are available for N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide?

Accepted Answer

N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide is available in the following size(s): 50 mg, 0.5 g.

Question 3

How many pack sizes does N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide come in?

Accepted Answer

N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide is available in 2 different pack sizes.

Question 4

Is N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide in stock?

Accepted Answer

N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

N- (5-Sulfamoyl-1,3,4-thiadiazol-2-yl) propanamide

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

Pmel17 / gp100 / SILV (NKI-beteb), CF594 conjugate, 0.1mg/mL

Complement C4d (C4D204), CF640R conjugate, 0.1mg/mL

CD59 (heavy chain of Protectin) (BRA-10G), CF647 conjugate, 0.1mg/mL

CD53 (161-2), CF647 conjugate, 0.1mg/mL

CD104 (UM-A9), CF488A conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL